Lydia Plachy

Growth Lead

Led commercial and strategy projects in Life Sciences and Global Public Health at McKinsey & Company, including work across commercial due diligence, market access, and growth strategies. Holds a Master's in Banking and Finance from the University of St. Gallen with a focus on data science and quantitative methods.

Articles by Lydia

Early detection

The four blood markers behind your B12 status

A normal B12 result tells you part of the story. Here's what better testing looks like.

Lydia Plachy20 Jul 2026

News

Daraxonrasib: the pancreatic cancer drug that doubled survival

Daraxonrasib doubled survival in metastatic pancreatic cancer. What the first targeted KRAS therapy means.

Lydia Plachy12 Jun 2026

Early detection

Chronic inflammation and your heart: the risk factor hiding in plain sight

Chronic inflammation cardiovascular risk goes undetected in most standard blood tests.

Lydia Plachy3 Jun 2026

Early detection

Chronic low-grade inflammation: a condition, not a symptom

Chronic inflammation works quietly for years. The right blood markers catch it early.

Lydia Plachy27 May 2026

Early detection

From PCOS to PMOS: why medicine is renaming a commonly misunderstood condition

The condition long known as PCOS has officially been renamed PMOS, reflecting a shift in how medicine understands one of the most common hormonal conditions affecting women today.

Lydia Plachy22 May 2026

Early detection

Closing the perimenopause gap: what an advanced blood test can tell you in your 30s and 40s

Perimenopause can begin a decade before your last period, bringing fatigue, brain fog, mood changes, and sleep disruption long before anyone thinks to check your hormones. A standard blood test often misses it.

Lydia Plachy15 May 2026

Early detection

Iron deficiency: what a full iron panel can tell you

Detecting iron deficiency: A complete iron panel goes beyond standard blood tests and can reveal early depletion of stores.

Lydia Plachy5 May 2026